Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 1:348:1-8.
doi: 10.1016/j.ijcard.2021.12.013. Epub 2021 Dec 11.

Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease

Puja K Mehta  1 , Odayme Quesada  2 , Ahmed Al-Badri  3 , Jerome L Fleg  4 , Annabelle Santos Volgman  5 , Carl J Pepine  6 , C Noel Bairey Merz  2 , Leslee J Shaw  7
Affiliations
Review

Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease

Puja K Mehta et al. Int J Cardiol. .

Abstract

A large proportion of patients with suspected obstructive coronary artery disease (CAD) is found to have ischemia with no obstructive coronary artery disease (INOCA). Based on current evidence, these patients are at increased risk of adverse cardiovascular events, even though they have no obstructive CAD. Importantly, INOCA is associated with recurrent clinical presentations with chest pain, impaired functional capacity, reduced health-related quality of life, and high healthcare costs. Underlying coronary microvascular dysfunction (CMD), through endothelium-dependent and independent mechanisms contribute to these adverse outcomes in INOCA. While non-invasive and invasive diagnostic testing has typically focused on identification of obstructive CAD in symptomatic patients, functional testing to detect coronary epicardial and microvascular dysfunction should be considered in those with INOCA who have persistent angina. Current diagnostic methods to clarify functional abnormalities and treatment strategies for epicardial and/or microvascular dysfunction in INOCA are reviewed.

Keywords: Atherosclerosis; Coronary artery disease; Functional imaging; Ischemic heart disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Mechanisms Contributing to INOCA
In addition to epicardial atherosclerosis and epicardial coronary vasospasm, CMD is a major cause of abnormal coronary blood flow regulation. CMD-related functional and structural mechanisms contribute to impaired blood flow and ischemia. CAD: coronary artery disease; CMD: coronary microvascular dysfunction; VSMC: vascular smooth muscle cell. Created with BioRender.com.
Figure 2.
Figure 2.. Abnormal Coronary Vascular Function in INOCA and Outcomes
In women with no obstructive coronary artery disease, functional coronary angiography identifies those at higher risk for adverse events and angina hospitalizations. Epicardial coronary vascular reactivity can impact microvascular resistance to flow. A majority of patients with low coronary flow reserve also had abnormal epicardial coronary artery response to acetylcholine, and these pathways are inter-related. Reprinted with Permission from AlBadri et al.
Figure 3.
Figure 3.. Therapeutic Considerations in CMD Management
Treatment of CMD and associated abnormal vasoreactivity includes traditional anti-anginal medications to lower myocardial oxygen demand, as well as medications that improve endothelial function. Anti-nociceptive strategies can be helpful given the role of enhanced pain perception described in a subset of CMD subjects. ACE-I: angiotensin converting enzyme-inhibitors; EECP: Enhanced external counter pulsation *Patients may have overlapping abnormal pathways with low coronary flow reserve + smooth muscle dysfunction.
See this image and copyright information in PMC

References

    1. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–e228. - PubMed
    1. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 2014;64(18):1929–1949. - PubMed
    1. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886–895. - PMC - PubMed
    1. Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation. 2017;135(11):1075–1092. - PMC - PubMed
    1. Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J. 2020;41(37):3504–3520. - PMC - PubMed

MeSH terms